LASS1 anticorps (AA 301-350)

N° du produit ABIN564667

Détail du produit anti-LASS1 anticorps

Antigène: LASS1 (CERS1) (Ceramide Synthase 1 (CERS1))

Épitope: AA 301-350

Reactivité: Humain

Hôte: Souris

Clonalité: Polyclonal

Conjugué: Cet anticorp LASS1 est non-conjugé

Application: Western Blotting (WB), ELISA

Fonction: Mouse polyclonal antibody raised against a partial recombinant LASS1.

Séquence: YIVAFAAKVL TGQVHELKDL REYDTAEAQS LKPSKAEKPL RNGLVKDKRF

Réactivité croisée: Humain

Attributs du produit: Antibody Reactive Against Recombinant Protein.

Immunogène: LASS1 (NP_067090, 301 a.a. ~ 350 a.a) partial recombinant protein with GST tag.

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 50 % glycerol

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-LASS1 (ABIN564667)

Separovic, Breen, Joseph, Bielawski, Pierce, VAN Buren, Gudz: "Ceramide synthase 6 knockdown suppresses apoptosis after photodynamic therapy in human head and neck squamous carcinoma cells." dans: Anticancer research, Vol. 32, Issue 3, pp. 753-60, (2012) (PubMed).

Separovic, Breen, Joseph, Bielawski, Pierce, VAN Buren, Gudz: "siRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy." dans: Anticancer research, Vol. 32, Issue 7, pp. 2479-85, (2012) (PubMed).

Haddad, Khoury, Daoud, Kantar, Harati, Mousallem, Alzate, Meyer, Boustany: "CLN5 and CLN8 protein association with ceramide synthase: biochemical and proteomic approaches." dans: Electrophoresis, Vol. 33, Issue 24, pp. 3798-809, (2012) (PubMed).

Senkal, Ponnusamy, Bielawski, Hannun, Ogretmen: "Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways." dans: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 24, Issue 1, pp. 296-308, (2010) (PubMed).

Senkal, Ponnusamy, Rossi, Bialewski, Sinha, Jiang, Jazwinski, Hannun, Ogretmen: "Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas." dans: Molecular cancer therapeutics, Vol. 6, Issue 2, pp. 712-22, (2007) (PubMed).

Détails sur LASS1

Antigène: LASS1 (CERS1) (Ceramide Synthase 1 (CERS1))

Autre désignation: LASS1 (CERS1 Produits)

Synonymes: anticorps LAG1, anticorps LASS1, anticorps UOG1, anticorps Lass1, anticorps Uog-1, anticorps to, anticorps LAG1 HOMOLOG 1, anticorps LONGEVITY ASSURANCE GENE 1, anticorps ceramide synthase 1, anticorps TRAM, LAG1 and CLN8 (TLC) lipid-sensing domain containing protein, anticorps CERS1, anticorps Cers1, anticorps LAG1

Sujet: Full Gene Name: LAG1 homolog, ceramide synthase 1
Synonyms: CerS1,LAG1,MGC90349,UOG1

ID gène: 10715

NCBI Accession: NM_021267